London 27th September 2019:NMC Health plc (LSE:NMC) ('NMC'), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, announces that on 26th September 2019, Prasanth Manghat (Chief Executive Officer and Executive Director), exercised various nil-cost share options over 133,728 shares, granted to him in 2016, 2017 & 2018 under the Company's Long Term Investment Plans ("LTIP") and Deferred Share Bonus Plans ("DSBP").
Following this transaction, Mr Manghat has an interest over a total of 388,000 shares, representing approximately 0.18% of the issued share capital of the Company.
The Notification of Dealing Form for Mr Manghat can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Details of the person discharging managerial responsibilities / person closely associated
Reason for the notification
Chief Executive Officer and Executive Director
Initial notification /Amendment
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
NMC Health plc
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument Identification code
Options over ordinary Shares
Nature of the transaction
Exercise of Nil-cost options
Price(s) and volume(s)
Total Shares for allotment
No. of shares
Date of the transaction
26 September 2019
Place of the transaction
Not on a trading venue
Simon Watkins, Group Company Secretary
+44 (0)20 3205 7313
FTI Consulting, London
+44 (0)20 3727 1000
FTI Consulting, Gulf
+971 (0)4 437 2100
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...